Log in to search using one of your social media accounts:

 

Fountain honors donors who, at the time of death, gave life to others

Two years ago, Rachel Greenberg of Marina del Rey went out to run a few errands. While she was gone, her husband Glenn suffered a massive brain hemorrhage. He was immediately taken to Ronald Reagan UCLA Medical Center where physicians explained he had suffered the worst kind of brain bleed. They operated, but after four days it was clear that the hemorrhage had caused too much damage, and he would not survive. Glenn was kept on a ventilator until family members from the East Coast could arrive. During this vigil, Rachel learned that when Glenn had renewed his driver’s license a few months earlier, he had signed up to become an organ donor.    “In the midst of the most unimaginable grief and shock, I felt pride for Glenn’s decision to be a donor in what would be the last chapter of his life,” said Rachel. “Now he lives on in others.” Glenn’s donation went on to help 89 individuals, ranging in age from 19 to 92 years old.  “Organ donation is a positive and powerful thing we can do to help families and loved ones transition from grief to opportunity to help others who are in need,” said Dr. Paul Vespa, director of neurocritical care at Reagan UCLA Medical Center and a professor of neurosurgery and neurology at the David Geffen School of Medicine at UCLA. Todd Cheney/UCLA Dr. James Atkinson, interim associate vice chancellor and president of the UCLA Hospital System, is flanked on the left by Rachel Greenberg, ...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news

Related Links:

The ENDURANCE Supplemental trial was designed to assess the effectiveness of an enhanced blood pressure (BP) management protocol in reducing the occurrence of neurological events in patients ineligible for cardiac transplantation receiving the Medtronic HeartWareTM HVADTM System. The trial demonstrated that enhanced BP management significantly reduced the mean arterial pressure (MAP) and the incidence of hemorrhagic strokes compared to the original ENDURANCE trial. This subsequent analysis sought to understand the effects of BP management on stroke severity and recovery.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research
Time limit: 0 Quiz-summary 0 of 20 questions completed Questions: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Information This test series requires login for attempting. You can login easily with your Facebook account (Use the CONNECT WITH icon on the upper part of right sidebar displaying t...
Source: Cardiophile MD - Category: Cardiology Authors: Tags: General Cardiology Source Type: blogs
This article does not contain any studies with human participants or animals performed by the author. Data Availability All national (MagIran, Science Information Database (SID) and Iranmedex) and international (PubMed, Scopus) databases were searched from November 2010 to November 2016 using keywords both in English and Persian: Afghan immigrants, Afghan refugees, Iran, infectious diseases, tuberculosis, HIV, Hepatitis B and C, non-communicable disease, food security, mental health, barriers, health insurance, access to health service. All related websites and webpages were also searched by Google with the same keywords ...
Source: PLOS Currents Disasters - Category: International Medicine & Public Health Authors: Source Type: research
This article does not contain any studies with human participants or animals performed by the author. Data Availability All national (MagIran, Science Information Database (SID) and Iranmedex) and international (PubMed, Scopus) databases were searched from November 2010 to November 2016 using keywords both in English and Persian: Afghan immigrants, Afghan refugees, Iran, infectious diseases, tuberculosis, HIV, Hepatitis B and C, non-communicable disease, food security, mental health, barriers, health insurance, access to health service. All related websites and webpages were also searched by Google with the same keywords ...
Source: PLOS Currents Disasters - Category: International Medicine & Public Health Authors: Source Type: research
Medtronic (NYSE:MDT) said today that results from the Endurance supplemental trial of its HVAD heart pump system did not meet its primary endpoint, but did report  lowered stroke rates compared to standard treatment. The trial aimed to evaluate the use of the HVAD system, which it picked up along with HeartWare last year, as a destination therapy for patients who require a left ventricular assist device and received improved blood pressure management, the Fridley, Minn.-based company said. Data from the study was presented at the 2017 International Society for Heart and Lung Transplantation Scientific Meeting in ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Cardiac Assist Devices Cardiovascular Clinical Trials HeartWare International Inc. Medtronic Source Type: news
Pump thrombosis confers significant morbidity and mortality in left ventricular assist device (LVAD) supported patients. Particularly in HVAD, therapeutic approaches including thrombolysis, or adjusting anticoagulation have been recommended as initial treatment but are associated with hemorrhagic stroke and death. Conversely, device exchange has been recommended as a preferred choice with low morbidity-mortality. Biventricular support (BIVAD) utilizing 2 HVAD systems has been proven as a novel way to manage critically ill individuals with biventricular failure.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research
Pentobarb coma – BIS should be 10-20 and SR (suppression ratio) should be 70-80 Consider lev albuterol Should give vaccines after coiling of spleen or before if possible No calcium channel blockers post MI definitely and post op in general Toradol inhibits spine healing Don’t do endoscopes with patients in supine position don’t ambulate patients with known dvt’s. wait 2-3 days until clots get stuck. dvt’s even with filter get heparin as much as possible for post phlebitic syndrome and to retard new clot formation diffuse alveolar hemorrhage – secondary to chemo, goodpasture’s, wege...
Source: Inside Surgery - Category: Surgery Authors: Tags: General Source Type: blogs
Stroke is a major cause of mortality following left ventricular assist device (LVAD) placement.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
Stroke is a major cause of mortality after left ventricular assist device (LVAD) placement.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Clinical Science Source Type: research
This study builds on preliminary findings from the first phase of the INTERSTROKE study, which identified ten modifiable risk factors for stroke in 6,000 participants from 22 countries. The full-scale INTERSTROKE study included an additional 20,000 individuals from 32 countries in Europe, Asia, America, Africa and Australia, and sought to identify the main causes of stroke in diverse populations, young and old, men and women, and within subtypes of stroke. To estimate the proportion of strokes caused by specific risk factors, the investigators calculated the population attributable risk for each factor (PAR; an esti...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
More News: Brain | Health | Hemorrhagic Stroke | Hospitals | Intensive Care | Lung Transplant | Neurology | Neurosurgery | Nurses | Nursing | Transplant Surgery | Transplants | Universities & Medical Training